Clinical trials
Phase 2/3 trials in Latvia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 6 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 3 |
| AbbVie | 2 |
| AstraZeneca | 2 |
| Eli Lilly and Company | 2 |
| EyeBiotech Ltd. | 2 |
| Novartis Pharmaceuticals | 2 |
| Aerovate Therapeutics | 1 |
| Astellas Pharma Europe B.V. | 1 |
| Biotronik, Inc. | 1 |
| Corxel Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis, Ulcerative | 5 |
| Macular Degeneration | 2 |
| Multiple Sclerosis, Chronic Progressive | 2 |
| Wet Macular Degeneration | 2 |
| Asthma | 1 |
| Choroidal Neovascularization | 1 |
| Colorectal Neoplasms | 1 |
| Crohn Disease | 1 |
| Depressive Disorder | 1 |
| Diabetes Mellitus, Type 1 | 1 |
Trials
Showing 76 to 28 of 28. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.